These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 33448107)
1. Circulating tumor cell profiling for precision oncology. Labib M; Kelley SO Mol Oncol; 2021 Jun; 15(6):1622-1646. PubMed ID: 33448107 [TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells: a multifunctional biomarker. Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms. Paoletti C; Cani AK; Larios JM; Hovelson DH; Aung K; Darga EP; Cannell EM; Baratta PJ; Liu CJ; Chu D; Yazdani M; Blevins AR; Sero V; Tokudome N; Thomas DG; Gersch C; Schott AF; Wu YM; Lonigro R; Robinson DR; Chinnaiyan AM; Bischoff FZ; Johnson MD; Park BH; Hayes DF; Rae JM; Tomlins SA Cancer Res; 2018 Feb; 78(4):1110-1122. PubMed ID: 29233927 [TBL] [Abstract][Full Text] [Related]
4. Using CTCs for pharmacogenomic analysis. Hart CD; Galardi F; Pestrin M; De Luca F; Risi E; Di Leo A Pharmacol Res; 2016 Apr; 106():92-100. PubMed ID: 26921662 [TBL] [Abstract][Full Text] [Related]
5. Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs. Vismara M; Reduzzi C; Daidone MG; Cappelletti V Adv Exp Med Biol; 2020; 1220():81-91. PubMed ID: 32304081 [TBL] [Abstract][Full Text] [Related]
6. Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity. Tellez-Gabriel M; Heymann MF; Heymann D Theranostics; 2019; 9(16):4580-4594. PubMed ID: 31367241 [TBL] [Abstract][Full Text] [Related]
7. Biological and Molecular Characterization of Circulating Tumor Cells: A Creative Strategy for Precision Medicine? Chen S; El-Heliebi A; Kroneis T Adv Clin Chem; 2017; 82():71-103. PubMed ID: 28939214 [TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy: current technology and clinical applications. Nikanjam M; Kato S; Kurzrock R J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847 [TBL] [Abstract][Full Text] [Related]
10. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer. Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345 [TBL] [Abstract][Full Text] [Related]
11. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications. Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682 [TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook. Tinhofer I; Staudte S Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647 [TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells: A step toward precision medicine in hepatocellular carcinoma. Teng PC; Agopian VG; Lin TY; You S; Zhu Y; Tseng HR; Yang JD J Gastroenterol Hepatol; 2022 Jul; 37(7):1179-1190. PubMed ID: 35543075 [TBL] [Abstract][Full Text] [Related]
14. Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives. Gribko A; Künzel J; Wünsch D; Lu Q; Nagel SM; Knauer SK; Stauber RH; Ding GB Int J Nanomedicine; 2019; 14():4187-4209. PubMed ID: 31289440 [TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells (CTCs) as a liquid biopsy material and drug target. Cai LL; Ye HM; Zheng LM; Ruan RS; Tzeng CM Curr Drug Targets; 2014; 15(10):965-72. PubMed ID: 25182470 [TBL] [Abstract][Full Text] [Related]
16. Microfluidics and circulating tumor cells. Dong Y; Skelley AM; Merdek KD; Sprott KM; Jiang C; Pierceall WE; Lin J; Stocum M; Carney WP; Smirnov DA J Mol Diagn; 2013 Mar; 15(2):149-57. PubMed ID: 23266318 [TBL] [Abstract][Full Text] [Related]
17. Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing. Kujur PK; Flores BCT; Ramalingam N; Chinen LTD; Jeffrey SS Adv Exp Med Biol; 2020; 1220():61-80. PubMed ID: 32304080 [TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells in breast cancer: applications in personalized medicine. Lee JS; Magbanua MJM; Park JW Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678 [TBL] [Abstract][Full Text] [Related]
19. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level. Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S Cells; 2020 Aug; 9(8):. PubMed ID: 32784507 [TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel. Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]